跳到正文
iScience· Cheng·收录于· 20 小时前

Survival after neoadjuvant versus adjuvant chemotherapy in operable hormone receptor-positive HER2-negative breast cancer

Survival after neoadjuvant versus adjuvant chemotherapy in operable hormone receptor-positive HER2-negative breast cancer

来源:iScience · doi.org